• Fusion to Build Radiopharma Manufacturing Facility contractpharma
    June 08, 2021
    ​Fusion Pharmaceuticals, a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, has entered a 15-year lease agreement with Hamilton, Ontario-based McMaster University to build a 27,000 ...
  • Fusion Pharmaceuticals Acquires IPN-1087 contractpharma
    March 03, 2021
    Fusion Pharmaceuticals Inc. has entered into an asset purchase agreement (APA) to acquire Ipsen's intellectual property and assets related to IPN-1087.
PharmaSources Customer Service